Clear cell renal carcinoma brain metastases

• Clear Cell Renal Cell Carcinoma With Brain Metastases Treated With Complementary Ketogenic Metabolic Therapy: A Case Report
• Evaluation of primary venous thromboembolism prophylaxis in hospitalized patients with primary brain tumors or secondary brain metastases
• Peptide Hydrogels for Renal Carcinoma Therapy via Synergistic Inhibition of Glycolysis and Mitochondrial Metabolism Reprogramming
• Current status of adjuvant immunotherapy and relapse management in renal cell carcinoma: Insights from a European delphi study
• Metastatic renal cell carcinoma to the glans penis: A case report of rare presentation
• Importance of Apparent Diffusion Coefficient in Differentiation of Cerebral Tumors
• Unilateral Pheochromocytoma in Von Hippel-Lindau Syndrome Revealed by a Hemangioblastoma
• Predictive Factors for Multiple Metastases of Clear-cell Renal Cell Carcinoma

Clear cell renal carcinoma brain metastases treatment.

1. Psoriasis.
2. Left ankle fracture, surgically treated.
3. Breast cancer treated with surgery and radiotherapy.
4. Renal neoplasm with nephrectomy.

Current Illness: - A 62-year-old patient with asthenia, headache, apathy, bradypsychia, lack of concentration, and changes in personality and behavior. A right frontal lesion measuring 5 cm and a left cerebellar lesion measuring 1 cm were identified.

Physical Examination: - Bradypsychia, left central facial paresis, mild paresis in the left arm, and positive neurological signs on the left side were observed.

Complementary Examination:

- Imaging studies: Right frontal lesion measuring 5x4x4 cm with edema, ventricular collapse, and a 1 cm lesion in the left cerebellum. Ventricular system compression and subfalcine herniation were noted.

Previous Intervention: - A craniotomy with excision of the right frontal lesion was performed.

Histopathology: - Clear cell renal carcinoma, consistent with metastasis from a known renal primary tumor.

Oncological Evolution: - Brain recurrence with lesions in the right frontal lobe and left cerebellum. Treatment with radiotherapy and radiosurgery was administered. - Systemic immunotherapy was initiated but discontinued due to complications. - Progression of brain metastases.

Treatment Plan: - Referral for postoperative radiotherapy.

Age: 59 years Relevant Medical History: Hypertension (HTA), Type 2 Diabetes Mellitus (DM2).

Current Medications:

Bisoprolol 5mg, 1 tablet every 24 hours.

Metformin 1000mg, 1 tablet every 12 hours.

Omeprazole 20mg, 1 capsule every 24 hours.

Ferbisol (Iron) 100mg, 1 capsule every 24 hours.

Escitalopram 10mg, 1 tablet every 24 hours.

Oncological History:

Stage IV clear cell carcinoma with pulmonary metastases.

Previous treatments: Right nephroureterectomy, SBRT RADICAL TOTAL DOSE 60Gy, Nivolumab-Ipilimumab, Cabozantinib.

Clinical Presentation:

Progressive weakness and asthenia. Dizziness, instability, intense holocranial headache.

Radiological Findings:

Brain MRI: Space-occupying lesion in the right frontal lobe suggestive of brain metastasis.

TAP CT: Findings secondary to known oncological history, without significant progression signs. Postoperative Brain CT: Post-right frontal craniotomy changes without clear evidence of residual tumor. Surgical Procedure:

Craniotomy and resection of the brain tumor.

Postoperative Evolution:

Improvement of preoperative clinical status. Conscious, oriented, without new neurological focal deficits. Autonomous ambulation

Afebrile, no signs of wound infection. Postoperative images without complications or significant tumor remnants.

Management Plan:

Referral to Oncology and Radiotherapy for evaluation and management on the surgical bed. Hospital discharge with follow-up in Neurosurgery outpatient clinics. Comment: The patient has experienced a favorable evolution after the resection of the brain tumor, without significant postoperative complications. Multidisciplinary follow-up is planned to address the primary and secondary diseases.